Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report. Multinational pharmaceutical giant Read More
© 2023 The Token View | All rights reserved. | Powered by Block Busters Tech Inc.
Stay informed with our curated information and offers just for subscribers.